Kotak Bank stock split: This would be the private lender’s second stock split. The earlier split took place in September 2010, when the face value of the shares was reduced to Rs 5 each from Rs 10.

Stock splits don’t boost intrinsic value, but they lead to higher trading volumes and more attention from investors. Identifying stocks before splits are announced can lead to higher returns, but it’s ...

Nuvama Wealth Management is set to see a sharp decline in its quoted share price on Friday, December 26, as the stock turns ex-date for its maiden split, post spin off and listing in 2023. Today is ...

Stock splits are a powerful tool for investors that provide portfolio leverage. While a stock split does nothing to alter the fundamental quality of the business of the stock value, companies that ...

Netflix has not completed a stock split in almost a decade. Stock splits do not inherently change the value of a company. The upcoming split, as well as the newest installment of "Stranger Things" ...

Microsoft is one of the highest-priced components of the Dow Jones Industrial Average. Microsoft is reaping massive benefits as demand for AI infrastructure keeps rising. The stock has gotten a bit ...

Splits aren't so sweet for large-cap, high-priced stocks Netflix Inc (NASDAQ:NFLX) recently announced a 10-for-1 stock split, with trading on a split-adjusted basis set to begin next week. Most ...

Netflix will trade on a post-split basis on Nov. 17. A stock split is a discretionary move by management that doesn't fundamentally affect the stock. When a company announces a stock split, it's ...

SAN DIEGO--(BUSINESS WIRE)--Nuvve Holding Corp. (“Nuvve” or the “Company”) (Nasdaq: NVVE), a global leader in distributed grid assets management and vehicle-to-grid (V2G) technology, today announced ...

SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...

The MarketWatch News Department was not involved in the creation of this content. SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...